Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT01540747

NCT01540747
Completed Phase 4

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Polycystic Ovary Syndrome (PCOS), a hormonal condition affecting the ovaries
  • Your menstrual cycle is irregular, lasting longer than 28-30 days
  • Your uterus has been found to be normal in shape and structure
  • Your Body Mass Index (BMI) — a measure of body weight relative to height — is between 20 and 26
  • This would be your first time undergoing IVF (in vitro fertilisation) treatment

Who may not be able to join:

  • Your infertility has been found to be caused by problems with the fallopian tubes, the uterus, genetics, or your partner's sperm
  • You have been diagnosed with cancer
  • You have received any hormone-based treatment within the last six months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 4: approximately Approved of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 4
Sponsor
AGUNCO Obstetrics and Gynecology Centre
Registry
clinicaltrials_gov

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Number of mature oocytes; embryo quality; Pregnancy rate; Implantation rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov